V A Morrison
Overview
Explore the profile of V A Morrison including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
43
Citations
1768
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Hari P, Romanus D, Henk H, Becker L, Noga S, Morrison V
J Clin Pharm Ther
. 2017 Aug;
43(1):45-51.
PMID: 28833305
What Is Known And Objective: Second-line therapy (SLT) trials in relapsed/refractory multiple myeloma (RRMM) report superior outcomes with triplet combinations. We sought to determine factors associated with triplet SLT in...
2.
Stauder R, Eichhorst B, Hamaker M, Kaplanov K, Morrison V, Osterborg A, et al.
Ann Oncol
. 2016 Nov;
28(2):218-227.
PMID: 27803007
Chronic lymphocytic leukemia (CLL) mainly affects older people: the median age at diagnosis is > 70 years. Elderly patients with CLL are heterogeneous with regard both to the biology of...
3.
Morrison V, Hamlin P, Soubeyran P, Stauder R, Wadhwa P, Aapro M, et al.
Ann Oncol
. 2015 Jan;
26(6):1058-1068.
PMID: 25635006
Diffuse large B-cell lymphoma (DLBCL) is a treatable and potentially curable malignancy that is increasing in prevalence in the elderly. Until recently, older patients with this malignancy were under-represented on...
4.
Kauffman C, Freifeld A, Andes D, Baddley J, Herwaldt L, Walker R, et al.
Transpl Infect Dis
. 2014 Mar;
16(2):213-24.
PMID: 24589027
Background: Invasive fungal infections are a major cause of morbidity and mortality among solid organ transplant (SOT) and hematopoietic cell transplant (HCT) recipients, but few data have been reported on...
5.
Hong F, Habermann T, Gordon L, Hochster H, Gascoyne R, Morrison V, et al.
Ann Oncol
. 2014 Feb;
25(3):669-674.
PMID: 24567515
Background: The role of body mass index (BMI) in survival outcomes is controversial among lymphoma patients. We evaluated the association between BMI at study entry and failure-free survival (FFS) and...
6.
Schmader K, Oxman M, Levin M, Johnson G, Zhang J, Betts R, et al.
Clin Infect Dis
. 2012 Jul;
55(10):1320-8.
PMID: 22828595
Background: The Shingles Prevention Study (SPS; Department of Veterans Affairs Cooperative Study 403) demonstrated that zoster vaccine was efficacious through 4 years after vaccination. The Short-Term Persistence Substudy (STPS) was...
7.
Blaes A, Cavert W, Morrison V
Transpl Infect Dis
. 2009 Jun;
11(4):313-7.
PMID: 19497074
Malassezia furfur is a yeast that can cause a variety of infections, most commonly in normal hosts, and also in immunocompromised hosts. This yeast typically colonizes the skin, and is...
8.
Oxman M, Levin M, Johnson G, Schmader K, Straus S, Gelb L, et al.
N Engl J Med
. 2005 Jun;
352(22):2271-84.
PMID: 15930418
Background: The incidence and severity of herpes zoster and postherpetic neuralgia increase with age in association with a progressive decline in cell-mediated immunity to varicella-zoster virus (VZV). We tested the...
9.
Morrison V
Expert Rev Anticancer Ther
. 2002 Jul;
1(1):84-90.
PMID: 12113137
Infections remain a major cause of morbidity and mortality in patients with chronic lymphocytic leukemia. These patients are predisposed to infection due to the immune compromise inherent to the primary...
10.
Morrison V, Picozzi V, Scott S, Pohlman B, Dickman E, Lee M, et al.
Clin Lymphoma
. 2001 Nov;
2(1):47-56.
PMID: 11707870
The purpose of this historical case series study was to evaluate the association of age on delivered dose intensity of initial CHOP (cyclophosphamide/doxorubicin/ vincristine/prednisone) chemotherapy and the occurrence of hospitalizations...